Unknown

Dataset Information

0

Unveiling the Molecular Mechanisms Driving the Capsaicin-Induced Immunomodulatory Effects on PD-L1 Expression in Bladder and Renal Cancer Cell Lines.


ABSTRACT: The blockade of the PD-L1/PD-1 immune checkpoint has promising efficacy in cancer treatment. However, few patients with bladder cancer (BC) or renal cell carcinoma (RCC) respond to this approach. Thus, it is important to implement a strategy to stimulate the immune anti-tumor response. In this scenario, our study evaluated the effects of a low capsaicin (CPS) dose in BC and RCC cell lines. Western blot, qRT-PCR and confocal microscopy were used to assess PD-L1 mRNA and protein expression. Alterations to the cellular oxidative status and changes to the antioxidant NME4 levels, mRNA modulation of cytokines, growth factors, transcriptional factors and oncogene, and the activation of Stat1/Stat3 pathways were examined using Western blot, cytofluorimetry and qRT-PCR profiling assays. In BC, CPS triggers an altered stress oxidative-mediated DNA double-strand break response and increases the PD-L1 expression. On the contrary, in RCC, CPS, by stimulating an efficient DNA damage repair response, thus triggering protein carbonylation, reduces the PD-L1 expression. Overall, our results show that CPS mediates a multi-faceted approach. In modulating PD-L1 expression, there is a rationale for CPS exploitation as a stimulus that increases BC cells' response to immunotherapy or as an immune adjuvant to improve the efficacy of the conventional therapy in RCC patients.

SUBMITTER: Morelli MB 

PROVIDER: S-EPMC9179445 | biostudies-literature | 2022 May

REPOSITORIES: biostudies-literature

altmetric image

Publications

Unveiling the Molecular Mechanisms Driving the Capsaicin-Induced Immunomodulatory Effects on PD-L1 Expression in Bladder and Renal Cancer Cell Lines.

Morelli Maria Beatrice MB   Marinelli Oliviero O   Aguzzi Cristina C   Zeppa Laura L   Nabissi Massimo M   Amantini Consuelo C   Tomassoni Daniele D   Maggi Federica F   Santoni Matteo M   Santoni Giorgio G  

Cancers 20220526 11


The blockade of the PD-L1/PD-1 immune checkpoint has promising efficacy in cancer treatment. However, few patients with bladder cancer (BC) or renal cell carcinoma (RCC) respond to this approach. Thus, it is important to implement a strategy to stimulate the immune anti-tumor response. In this scenario, our study evaluated the effects of a low capsaicin (CPS) dose in BC and RCC cell lines. Western blot, qRT-PCR and confocal microscopy were used to assess PD-L1 mRNA and protein expression. Altera  ...[more]

Similar Datasets

| S-EPMC8446416 | biostudies-literature
| S-EPMC5555220 | biostudies-literature
| S-EPMC9479218 | biostudies-literature
| S-EPMC6631458 | biostudies-literature
| S-EPMC8673706 | biostudies-literature
| S-EPMC6480014 | biostudies-literature
| S-EPMC8613983 | biostudies-literature
| S-EPMC4674298 | biostudies-literature
| S-EPMC4647139 | biostudies-literature
| S-EPMC6219206 | biostudies-literature